Evidence map›Paper›PMID 41040408›Full record

ArticlebioRxiv : the preprint server for biology2025

Inferring Personalized Cell-Cell Communication Networks in Colorectal Cancer with Individualized Causal Discovery.

Aodong Qiu, Binfeng Lu, Gregory F Cooper, Xinghua Lu, Lujia Chen

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aodong QiuDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, 15206, USA.
Binfeng LuCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA.
Gregory F CooperDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, 15206, USA.
Xinghua LuDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, 15206, USA.ORCID 0000-0002-8599-2269
Lujia ChenDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, 15206, USA.

Funding

Interpretable deep learning models for translational medicine RenewalR01LM012011 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tanner J. Freeman, XINGHUA LU · 2015 to 2026
$3.6M
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapyR01CA254274 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LU, BINFENG · 2021 to 2025
$1.9M
Developing a Novel Causal Discovery Framework to Unveil Individualized Cell-Cell Communication NetworksR01HG014023 · NHGRI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Lujia Chen · 2025 to 2026
$1.4M
Developing deep learning models for precision oncologyR00LM013089 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, LUJIA · 2022 to 2024
$691k
NCI NIH HHS R01 CA254274NHGRI NIH HHS R01 HG014023NLM NIH HHS R00 LM013089NLM NIH HHS R01 LM012011
6 · The paper itself

Abstract

Understanding tumor heterogeneity at the resolution of individualized cell-cell communication networks (CCCNs) remains a major computational challenge in precision oncology. Existing inference methods largely rely on population-level correlation and thus fail to capture patient-specific signaling patterns across diverse cell types. To address this limitation, we developed an integrative computational framework combining the nested hierarchical Dirichlet process (nHDP) model for identifying hierarchically structured gene expression modules, with instance-specific Greedy Fast Causal Inference (iGFCI) for inferring individualized CCCNs (iCCCNs) in colorectal cancer (CRC). Applied to large-scale single-cell RNA-seq data from over 625,000 cells, our model successfully decomposed complex gene expression modules GEMs, potentially representing the cell lineage and cellular signaling states, and uncovered iCCCNs across detailed cell subtypes. We further used TCGA bulk RNA-seq data with survival data to validate the clinical relevance of these individualized gene expression module causal interactions, demonstrating their potential as robust prognostic signatures in CRC. Finally, we used principled causal inference methods to search for ligand-receptor pairs that mediate cell-cell communication. This framework enables mechanistic insights into immune evasion. Our computational method represents a significant advance toward realizing personalized oncology, enabling precise patient stratification and identification of actionable biomarkers for improved therapeutic targeting in cancers.

Indexed as

Causal Bayesian NetworksCausal DiscoveryCell-cell CommunicationColorectal CancerTumor Microenvironment

Identifiers

PMID41040408
PMCPMC12485737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.